- Home
- DNA vs PFN Comparison
DNA vs PFN Comparison
Compare DNA & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- PFN
- Stock Information
- Founded
- DNA 2008
- PFN 2004
- Country
- DNA United States
- PFN United States
- Employees
- DNA N/A
- PFN N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- PFN Finance/Investors Services
- Sector
- DNA Health Care
- PFN Finance
- Exchange
- DNA Nasdaq
- PFN Nasdaq
- Market Cap
- DNA 658.5M
- PFN 636.0M
- IPO Year
- DNA N/A
- PFN N/A
- Fundamental
- Price
- DNA $10.24
- PFN $7.44
- Analyst Decision
- DNA Sell
- PFN
- Analyst Count
- DNA 3
- PFN 0
- Target Price
- DNA $9.67
- PFN N/A
- AVG Volume (30 Days)
- DNA 1.6M
- PFN 331.7K
- Earning Date
- DNA 08-07-2025
- PFN 01-01-0001
- Dividend Yield
- DNA N/A
- PFN 11.66%
- EPS Growth
- DNA N/A
- PFN N/A
- EPS
- DNA N/A
- PFN N/A
- Revenue
- DNA $237,417,000.00
- PFN N/A
- Revenue This Year
- DNA N/A
- PFN N/A
- Revenue Next Year
- DNA $15.91
- PFN N/A
- P/E Ratio
- DNA N/A
- PFN N/A
- Revenue Growth
- DNA 13.76
- PFN N/A
- 52 Week Low
- DNA $5.00
- PFN $5.94
- 52 Week High
- DNA $16.85
- PFN $7.58
- Technical
- Relative Strength Index (RSI)
- DNA 53.69
- PFN 58.47
- Support Level
- DNA $8.21
- PFN $7.33
- Resistance Level
- DNA $13.33
- PFN $7.54
- Average True Range (ATR)
- DNA 0.92
- PFN 0.04
- MACD
- DNA -0.04
- PFN 0.01
- Stochastic Oscillator
- DNA 39.86
- PFN 67.74
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.